Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
|
US |
|
Allreal Holding AG
SIX:ALLN
|
CH |
|
F
|
Foxo Technologies Inc
AMEX:FOXO
|
US |
|
E
|
eEducation Albert AB
STO:ALBERT
|
SE |
|
Darma Henwa Tbk PT
IDX:DEWA
|
ID |
|
P
|
Photon Energy NV
WSE:PEN
|
NL |
|
K
|
Koroplast Temizlik Ambalaj Urunleri Sanayi ve Dis Ticaret AS
IST:KRPLS.E
|
TR |
|
Awilco LNG ASA
OSE:ALNG
|
NO |
|
Chemed Corp
NYSE:CHE
|
US |
|
N
|
NeoVolta Inc
NASDAQ:NEOV
|
US |
|
G
|
GDS Holdings Ltd
NASDAQ:GDS
|
CN |
Wall Street
Price Targets
ARCT Price Targets Summary
Arcturus Therapeutics Holdings Inc
According to Wall Street analysts, the average 1-year price target for
ARCT
is 25.78 USD
with a low forecast of 8.08 USD and a high forecast of 71.4 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ARCT's stock price target?
Price Target
25.78
USD
According to Wall Street analysts, the average 1-year price target for
ARCT
is 25.78 USD
with a low forecast of 8.08 USD and a high forecast of 71.4 USD.
What is Arcturus Therapeutics Holdings Inc's Revenue forecast?
Projected CAGR
-18%
The
compound annual growth rate
of
Arcturus Therapeutics Holdings Inc's revenue for the next 3 years is
-18%.